Navigation Links
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
Date:7/22/2009

ncer). There are approximately 200,000 new cases of breast cancer in the U.S. and 350,000 in Europe each year. More than 40,000 women in the U.S. die of breast cancer each year.(i)

Nexavar's Differentiated Mechanism

Nexavar, an oral anti-cancer therapy, is currently approved in more than 70 countries for liver cancer and in more than 80 countries for the treatment of patients with advanced kidney cancer. Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of two classes of kinases known to be involved in both cell proliferation (growth) and angiogenesis (blood supply) - two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators as a single agent or combination treatment in a wide range of cancers, including lung, ovarian and colorectal cancer and as an adjuvant therapy for liver and kidney cancer.

Important Safety Considerations For Patients Taking Nexavar

Based on the currently approved U.S. package insert for the treatment of patients with unresectable hepatocellular carcinoma and advanced kidney cancer, hypertension may occur early in the course of therapy and blood pressure should be monitored weekly during the first six weeks of therapy and treated as needed. In HCC patients, bleeding with a fatal outcome from any site was reported in 2.4% for Nexavar and 4% in placebo. The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. 1.3% for placebo. In RCC patients, incidence of bleeding regardless of causality was 15% for Nexavar vs. 8% for placebo and the incidence of treatment-emergent cardiac ischemia/infarction was 2.9% for Nexavar vs. 0.4% for placebo. Mo
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
2. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
3. Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
4. Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
5. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
6. Promising drug combination may help those with ocular melanoma that has spread
7. Combination therapy reverses effects of portal hypertension in rats
8. Combination vaccines okay for infants, study shows
9. Antidepressants and painkillers - a dangerous combination
10. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... St. Louis, MO (PRWEB) , ... July 31, 2015 , ... ... litigation* currently underway in U.S. District Court in the Northern District of Illinois, Androgel ... documents. On Monday, July 20, a docket entry was made recording the minutes of ...
(Date:7/31/2015)... ... July 31, 2015 , ... People ... when purchasing disability insurance, where price is an important factor to clients when ... leading insurance carrier, offers the Preferred Producer Multi-Life Discount program, where advisers pass ...
(Date:7/30/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... Floor:, Reduce Errors By 50% or More, **Presented by FDAnews and Ginette M. ... Ginette Collazo, a 15 year veteran of helping drug, biologic and device firms ...
(Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... program entitled " Lovetraction Lines ." It's for women interested in improving their ... they desire. The course, which officially launched to the public early this morning, ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 2Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 3Health News:Testosterone Lawsuit News: Androgel Lawsuit Conference Held 4Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2
... ... bomb is to explode in the coming years , ... London, UK (PRWEB) June 13, 2009 -- New images released by Lloydspharmacy show how ... affects around a quarter of the UK population, one of the highest prevalence rates for hayfever ...
... Calif., June 12 An independent factfinder jointly hired by Fresno ... County,s plan to cut the wages and benefits of 10,000 home ... and ordered that the cuts be halted. The Fresno Board of ... Tuesday. , , SEIU UHW invoked their right to arbitration ...
... Customs Enforcement Slow to Act, Not Doing Enough to Protect Employees, ... and Customs Enforcement Krome Service Processing Center in Miami, FL has ... has urged the agency for weeks to fit its personnel with ... with the H1N1 virus. "This is an outrage that it ...
... Ill., June 12 The American College of Chest ... historic 79-17 vote yesterday and the U.S. House of ... Food and Drug Administration meaningful authority to regulate tobacco ... represents the strongest legislation Congress has ever passed to ...
... says , FRIDAY, June 12 (HealthDay News) -- Here,s more ... about 4 percent of males develop dry eye disease, making ... for seeing an eye doctor in the United States, researchers ... or burning sensation in the eyes, according to the North ...
... ... largest online retailer of vision care products, unveils the newest addition to its collection ... organic, recycled material making them an environmentally friendly choice. , ... Vancouver, BC (PRWEB) - Clearly Contacts, the ...
Cached Medicine News:Health News:Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 2Health News:Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 3Health News:Neutral Factfinder Rules That Fresno County Home Care Wage Cuts Should Be Stopped 2Health News:Krome Immigration Service Processing Center Has Confirmed H1N1 Flu Cases 2Health News:American College of Chest Physicians Celebrates the Nation's Victory for Tobacco Control 2Health News:For Men Over 50, Odds of Eye Discomfort Increases 2Health News:Clearly Contacts Goes Green With Organic Glasses 2
(Date:7/31/2015)... 2015 Magnaquest, a leading ... and cloud computing operators has signed a Proof ... for Internet of Things (IoT) related initiative. The ... subscription model.      (Logo: http://photos.prnewswire.com/prnh/20140807/700645 ... for business innovations to make healthcare services more ...
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... an Interventional Radiology Treatment -- Detailed for Those ... Osteoplasty -- a highly effective minimally invasive procedure ... disease by injecting bone cement to support weakened ... often presenting individuals who are suffering terribly with ...
... Any Age: Comparison by Interventional Radiologists Shows No ... FistulasSAN DIEGO, March 9 A new study ... disease, it doesn,t matter if you,re young or ... for maintaining access to one,s circulatory system to ...
Cached Medicine Technology:Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 2Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 3Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 4Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 5For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 2For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 3For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold 4
Inquire...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
Inquire...
... Scientific PSE Power Supply . The digital ... V and 2 A in 1 volt and ... run up to three SEA 2000® apparatus simultaneously ... preset and actual values of voltage, current and ...
Medicine Products: